Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cardica Inc. (CRDC): Broadfin Capital, Kevin Kotler Send Another Letter To The Board

In a recent filing with the  Securities and Exchange Commission, Broadfin Capital has disclosed a letter sent to the Board of Directors of Cardica, Inc. (NASDAQ:CRDC). The letter contains the fund’s plea to the Board to allow a broader involvement of major shareholders in the process of decision making to solve strategic problems and also the list of nominees to be elected to the Board at the company’s 2014 Annual Shareholders Meeting. Broadfin Capital and its manager, Kevin Kotler, hold 8.87 million shares, which account for 9.98% of Cardica, Inc. (NASDAQ:CRDC)’s common stock, which makes them the largest shareholder.

Kevin Kotler

Broadfin Capital is unhappy with the Board’s failure to engage in a meaningful and constructive exchange of ideas to address the Cardica, Inc. (NASDAQ:CRDC)’s strategic issues and has called for an amicable agreement. If that does not happen, Broadfin and Kotler will insist on a proxy contest. The fund has also nominated Gregory D. Casciaro, R. Michael Kleine, Kevin Kotler and Samuel E. Navarro for election as directors at the company’s 2014 Annual Shareholders Meeting to take place on November 12, 2014.

“Accordingly, today we are submitting in full compliance with the requirements of the Company’s Bylaws a formal nomination of four individuals, Gregory D. Casciaro, R. Michael Kleine, Kevin Kotler and Samuel E. Navarro, for election to the Board at the 2014 Annual Meeting. We have conducted a thorough and thoughtful search for the best-suited candidates for Cardica and firmly believe that our four nominees are those candidates and will each be a valuable addition to the Board.”

“We continue to firmly believe that the cost and time of a proxy contest can and should be avoided. While change on the Board is, in our view, urgently needed there is no legitimate reason why such change should not be brought about through a thoughtful and collaborative process between the current Board and Broadfin, as Cardica’s largest shareholder. Our objective is to bring shareholder representation and experienced and well respected operators on the Board.”

The full letter can be found here.

Stephen Dubois is also interested in Cardica, Inc. (NASDAQ:CRDC) and has initiated a position for his fund, Camber Capital Management, during the second quarter of 2014. In its latest 13F filing, Camber Capital has reported ownership of 8.37 million shares worth $9.54 million. Nathan Fischel is betting on this stock, having increased his fund’s stake by 42%. Fischel’s Dafna Capital Management reportedly holds 1.48 million shares valued at $1.69 million.

Disclosure: none.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!